Addiction

Telehealth providers say the Biden administration should reconsider proposed regulations that would make obtaining prescription controlled drugs harder.

Supervised injection or safe consumption sites are places people could go to use illegal drugs while being monitored by medical experts.

Residents and community health care workers are expressing concern about proposals around law enforcement arresting individuals using illicit drugs out in the open.

New Castle County is attempting to combat drug usage through a new wastewater drug monitoring system.

Pennsylvania Gov. Josh Shapiro said Tuesday that he's adding xylazine to Pennsylvania’s controlled substances list.

Historic settlement resolving claims against opioid companies is expected to bring Pennsylvania over $1 billion, internal division over how to spend said settlement on issue.

The latest research shows even moderate drinking is bad for your health. Plus, a special segment in time for spring gardening. And the latest on the Rutgers University strike.

Public health advocates and harm reduction proponents in Philadelphia have long fought to make the medication more accessible.

The DEA warns that xylazine-fentanyl mixtures are exacerbating the deadly consequences of the opioid crisis.

The U.S. Drug Enforcement Administration issued an alert Monday warning of a "sharp increase in the trafficking of fentanyl mixed with xylazine."

The first year of settlement funds from national opioid lawsuits have reached Camden County, where officials will prioritize treatment and naloxone access.

After some setbacks, the Pallet Village in Georgetown finally opens, housing nearly 50 people experiencing homelessness and other challenges.

The FDA is considering a nonprescription, over-the-counter version of Narcan’s nasal spray for opioid overdoses. But experts worry about affordability.

A Biden administration official used Camden County Correctional Facility’s addiction treatment program as a model example for the nation to build on.

Advisers to the FDA put the opioid overdose-reversal drug a step closer to being sold without a needing a prescription. But the price tag could prove to be a barrier for many.